These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17693425)

  • 1. Glutathione-dependent reduction of arsenate by glycogen phosphorylase a reaction coupled to glycogenolysis.
    Németi B; Gregus Z
    Toxicol Sci; 2007 Nov; 100(1):36-43. PubMed ID: 17693425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
    Gregus Z; Németi B
    Toxicol Sci; 2007 Nov; 100(1):44-53. PubMed ID: 17693424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: II. Enzymatic formation of arsenylated products susceptible for reduction to arsenite by thiols.
    Gregus Z; Roos G; Geerlings P; Németi B
    Toxicol Sci; 2009 Aug; 110(2):282-92. PubMed ID: 19478237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: I. The role of arsenolysis.
    Németi B; Gregus Z
    Toxicol Sci; 2009 Aug; 110(2):270-81. PubMed ID: 19474219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione-supported arsenate reduction coupled to arsenolysis catalyzed by ornithine carbamoyl transferase.
    Németi B; Gregus Z
    Toxicol Appl Pharmacol; 2009 Sep; 239(2):154-61. PubMed ID: 19248796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of arsenate to arsenite by human erythrocyte lysate and rat liver cytosol - characterization of a glutathione- and NAD-dependent arsenate reduction linked to glycolysis.
    Németi B; Gregus Z
    Toxicol Sci; 2005 Jun; 85(2):847-58. PubMed ID: 15788720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polynucleotide phosphorylase and mitochondrial ATP synthase mediate reduction of arsenate to the more toxic arsenite by forming arsenylated analogues of ADP and ATP.
    Németi B; Regonesi ME; Tortora P; Gregus Z
    Toxicol Sci; 2010 Oct; 117(2):270-81. PubMed ID: 20457661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione-dependent reduction of arsenate in human erythrocytes--a process independent of purine nucleoside phosphorylase.
    Németi B; Gregus Z
    Toxicol Sci; 2004 Dec; 82(2):419-28. PubMed ID: 15470234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraction-mediated glycogenolysis in mouse skeletal muscle lacking creatine kinase: the role of phosphorylase b activation.
    Katz A; Andersson DC; Yu J; Norman B; Sandstrom ME; Wieringa B; Westerblad H
    J Physiol; 2003 Dec; 553(Pt 2):523-31. PubMed ID: 12963789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive, nonradioactive assay of phosphorylase kinase through measurement of enhanced phosphorylase activity towards fluorogenic dextrin.
    Miyagawa D; Makino Y; Sato M
    J Biochem; 2016 Feb; 159(2):239-46. PubMed ID: 26378249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione synthetase promotes the reduction of arsenate via arsenolysis of glutathione.
    Németi B; Anderson ME; Gregus Z
    Biochimie; 2012 Jun; 94(6):1327-33. PubMed ID: 22426003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase.
    Kaiser A; Nishi K; Gorin FA; Walsh DA; Bradbury EM; Schnier JB
    Arch Biochem Biophys; 2001 Feb; 386(2):179-87. PubMed ID: 11368340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase works as an arsenate reductase in human red blood cells and rat liver cytosol.
    Gregus Z; Németi B
    Toxicol Sci; 2005 Jun; 85(2):859-69. PubMed ID: 15788719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric regulation of liver phosphorylase a: revisited under approximated physiological conditions.
    Ercan N; Gannon MC; Nuttall FQ
    Arch Biochem Biophys; 1996 Apr; 328(2):255-64. PubMed ID: 8645002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purine nucleoside phosphorylase as a cytosolic arsenate reductase.
    Gregus Z; Németi B
    Toxicol Sci; 2002 Nov; 70(1):13-9. PubMed ID: 12388830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme kinetics of muscle glycogen phosphorylase b.
    Walcott S; Lehman SL
    Biochemistry; 2007 Oct; 46(42):11957-68. PubMed ID: 17910419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Delayed activation of muscle glycogen phosphorylase b on incubation of the enzyme with adenosine-5'-monophosphate].
    Kurganov BI; Shchors EI; Chebotareva NA; Klinov SV
    Biokhimiia; 1995 Jan; 60(1):88-104. PubMed ID: 7696433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional structure of phosphorylase kinase at 22 A resolution and its complex with glycogen phosphorylase b.
    Vénien-Bryan C; Lowe EM; Boisset N; Traxler KW; Johnson LN; Carlson GM
    Structure; 2002 Jan; 10(1):33-41. PubMed ID: 11796108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the arsenate reducted by common reducing agents].
    Fu J; Xue P; Jin Y; He M
    Wei Sheng Yan Jiu; 2008 Jan; 37(1):19-21. PubMed ID: 18421855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.
    Oikonomakos NG; Tsitsanou KE; Zographos SE; Skamnaki VT; Goldmann S; Bischoff H
    Protein Sci; 1999 Oct; 8(10):1930-45. PubMed ID: 10548038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.